• Name:

    Dr. Chandrakant Bonde

  • Designation:

    Principal (M.Pharm, Ph.D, MBA)

  • Specialization:

    Pharmaceutical and Medicinal Chemistry

  • Email :

    chandrakant.bonde@ssrpharmacy.edu.in

  • Total Experience:

    24

  • Follow Us:

Interest areas

  • Design and development of new chemical entities (NCEs) as anti-HIV and Antitubercular agents.
  • Computer aided drug design
  • Stability indicating method development using LC-MS
  • Analytical and bio analytical method development of Active Pharmaceutical Ingredients (APIs)
  • Impurity synthesis of API

Research

  • Publications – 95 (International- 65, National-30)
  • Presentations- 15 (International- 06, National- 9)
  • Government-funded projects – 02
  • Consultancy Project: 02
  • Seed grant project :03
  • Government fellowship – 1 (BOYSCAST Fellwship) Science and Engineering Research Board (SERB), Department of Science and Technology (DST)

Awards

  • Recipient of BOYSCAST fellowship from Department of science and technology, New Delhi to carry out the research work St. John’s university New York.
  • Recipient of Most Cited Research Article award 2003-2006 from Elsevier Ltd, Oxford, UK.,
  • Received Junior Research Fellowship from Haffkine Institute for Training Research and Testing in the year 1998-2001.

Conferences/Workshops/Seminars attended

  • Fifty six conferences are attended including national and international.

Professional Memberships

  • Association of Pharmaceutical Teachers of India (APTI) – Life Membership
  • Indian Society of Technical Education
  • Indian Pharmaceutical Association
  • International congress of chemistry and environment

Recent Publications

  • Dabhi, M., Parmar, I., & Bonde, C. (2026). Targeting Estrogen Pathways in Breast Cancer: A Review of Current Therapies and Emerging Strategies. Cell Biochemistry and Function44(1), e70166.
  •  

    Patil, H., Kute, P., Bonde, C., Bhole, R., Chaudhari, S., Gawad, J., … Bhattarai, A. (2026). Repurposing of FDA-Approved Antiviral Drugs against Monkey Pox Virus: A Computational Targeting of VP39 Methyl transferase. In Silico Research in Biomedicine, 100259.

  • Sah, M. K., Pathak, R., Maharjan, J., Gawad, J., Palkar, M., Bonde, C., & Bhattarai, A. (2026). Leveraging Carbon Quantum Dots to Achieve UN Sustainable Development Goals in the Face of Climate Change. Climate Resilience and Sustainability5(1), e70034.
  • Dange, H., Bonde, C., Bonde, S., Pandya, K., Kumar, D., & Gawad, J. (2026). Artificial intelligence enhanced CRISPR based epigenomic editing: A brighter future in precision medicine. Human Gene, 201565.
  •  Thombre, S., Bonde, C., Kharkar, P., & Gawad, J. (2026). Comparative evaluation and selection of optimal QSAR-based machine learning model for liver toxicity prediction. Molecular Diversity, 1–21.
  •  Solanki, Y., Bonde, S., Sonwane, S., & Bonde, C. (2026). Chitosan derivatives for functional hydrogels: Advances, applications, and future prospects. Reactive and Functional Polymers, 106873.
  •  Thombre, S., Bonde, C., Bhole, R., Gawad, J., & Karwa, P. (2026). Artificial intelligence in impurity prediction: current landscape, challenges, and future directions. Journal of Computer-Aided Molecular Design40(1), 186.
  •  Shelke, M., Hussain, A., Bonde, C., Siddique, M. U. M., Danishuddin, Altamimi, M. A., … Alnemer, O. A. (2026). HSPiP, QbD, and Zeneth based green analysis and stability study of valsartan in the presence of mutagenic impurities: an in-silico study for predicting drug safety and quality control. Journal of Analytical Science and Technology17(1), 43.